Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trialDavid H. Miller, Xavier Montalbán, Thomas Weber et al.|The Lancet Neurology|2012Cited by 77
Table of contentsLisa A. Snider, Neal R. Swerdlow, Susan E. Swedo et al.|Biological Psychiatry|2005Cited by 0